Madeline Lemke1,2, Paul J Karanicolas1,2,3, Rogeh Habashi2, Ramy Behman1,3, Natalie G Coburn1,2,3, Sherif S Hanna2, Calvin H L Law1,2,3, Julie Hallet4,5. 1. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. 2. Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, T2-63, Toronto, ON, M4N 3M5, Canada. 3. Department of Surgery, University of Toronto, Toronto, ON, Canada. 4. Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, T2-63, Toronto, ON, M4N 3M5, Canada. julie.hallet@sunnybrook.ca. 5. Department of Surgery, University of Toronto, Toronto, ON, Canada. julie.hallet@sunnybrook.ca.
Abstract
BACKGROUND: Arterial lactate is frequently monitored to indicate tissue hypoxia and direct therapy. We sought to determine whether early post-hepatectomy lactate (PHL) is associated with adverse outcomes and define factors associated with PHL. METHODS: Hepatectomy patients at a single institution from 2003 to 2012 with PHL available were included. Univariable and multivariable analyses examined factors associated with PHL and the relationship between PHL and 30-day major morbidity (Clavien grade III-V), 90-day mortality, and length of stay (LOS). RESULTS: Of 749 hepatectomies, 490 were included of whom 71.4% had elevated PHL (≥2 mmol/L). Cirrhosis (coefficient 0.31, p = 0.039), Charlson comorbidity index (coefficient 0.05, p < 0.001), major resections (coefficient 0.34, p < 0.001), procedure time (coefficient 0.08, p < 0.001), and blood loss (coefficient 0.11, p < 0.001) were associated with PHL. As lactate increased from <2 to ≥6 mmol/L, morbidity rose from 11.6 to 40.6%, and mortality from 0.7 to 22.7%. PHL was independently associated with 90-day mortality (OR 1.52 p < 0.001) and 30-day morbidity (OR 1.19, p = 0.002), but not LOS (rate ratio 1.03, p = 0.071). CONCLUSION: Patients with elevated PHL in the initial postoperative period should be carefully monitored due to increased risk of major morbidity and mortality. Further research on the impact of lactate-directed fluid therapy is warranted.
BACKGROUND: Arterial lactate is frequently monitored to indicate tissue hypoxia and direct therapy. We sought to determine whether early post-hepatectomy lactate (PHL) is associated with adverse outcomes and define factors associated with PHL. METHODS: Hepatectomy patients at a single institution from 2003 to 2012 with PHL available were included. Univariable and multivariable analyses examined factors associated with PHL and the relationship between PHL and 30-day major morbidity (Clavien grade III-V), 90-day mortality, and length of stay (LOS). RESULTS: Of 749 hepatectomies, 490 were included of whom 71.4% had elevated PHL (≥2 mmol/L). Cirrhosis (coefficient 0.31, p = 0.039), Charlson comorbidity index (coefficient 0.05, p < 0.001), major resections (coefficient 0.34, p < 0.001), procedure time (coefficient 0.08, p < 0.001), and blood loss (coefficient 0.11, p < 0.001) were associated with PHL. As lactate increased from <2 to ≥6 mmol/L, morbidity rose from 11.6 to 40.6%, and mortality from 0.7 to 22.7%. PHL was independently associated with 90-day mortality (OR 1.52 p < 0.001) and 30-day morbidity (OR 1.19, p = 0.002), but not LOS (rate ratio 1.03, p = 0.071). CONCLUSION:Patients with elevated PHL in the initial postoperative period should be carefully monitored due to increased risk of major morbidity and mortality. Further research on the impact of lactate-directed fluid therapy is warranted.
Authors: Eva See Wah Cheng; Julie Hallet; Sherif S Hanna; Calvin H L Law; Natalie G Coburn; Jordan Tarshis; Yulia Lin; Paul J Karanicolas Journal: J Surg Res Date: 2015-08-13 Impact factor: 2.192
Authors: Marianne J Vandromme; Russell L Griffin; Jordan A Weinberg; Loring W Rue; Jeffrey D Kerby Journal: J Am Coll Surg Date: 2010-05 Impact factor: 6.113
Authors: J H James; K R Wagner; J K King; R E Leffler; R K Upputuri; A Balasubramaniam; L A Friend; D A Shelly; R J Paul; J E Fischer Journal: Am J Physiol Date: 1999-07
Authors: Omar Hyder; Carlo Pulitano; Amin Firoozmand; Rebecca Dodson; Christopher L Wolfgang; Michael A Choti; Luca Aldrighetti; Timothy M Pawlik Journal: J Am Coll Surg Date: 2013-03-09 Impact factor: 6.113
Authors: R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy Journal: Intensive Care Med Date: 2004-03-03 Impact factor: 17.440
Authors: Thomas A Aloia; Bridget N Fahy; Craig P Fischer; Stephen L Jones; Andrea Duchini; Joseph Galati; A Osama Gaber; R Mark Ghobrial; Barbara L Bass Journal: HPB (Oxford) Date: 2009-09 Impact factor: 3.647
Authors: Joanna W Etra; Malcolm H Squires; Sarah B Fisher; Daniel R Rutz; Benjamin M Martin; David A Kooby; Kenneth Cardona; Juan M Sarmiento; Charles A Staley; Shishir K Maithel; Maria C Russell Journal: HPB (Oxford) Date: 2014-05-18 Impact factor: 3.647